Skip to page content Search
Home / Programmes and Contracts / Community Pharmacy Programme / Integrated Community Pharmacy Services Agreement (ICPSA)

Integrated Community Pharmacy Services Agreement (ICPSA)

Please refer to Te Whatu Ora - For the health sector for up to date information as these pages are not updated after 16 December. Relevant information will be moved to the Te Whatu Ora website.

Skip to...

ICPSA Variation 4

Contract Structure

National Annual Agreement Review Process

There are just over 1000 community pharmacy providers throughout Aotearoa, and each provider has entered into a contract with Te Whatu Ora for the provision of pharmacy services.

The Integrated Community Pharmacy Services Agreement (ICPSA) came into effect on 1 October 2018. It is reviewed each year and the latest variation (variation 4) came into effect on 1 October 2022.

This section contains key information about the contract.  

Integrated Community Pharmacy Services Agreement [1.15MB]

1 October 2022

Integrated Community Pharmacy Services Agreement - Word document [304kb]

1 October 2022


Changes to ICPSA Variation 4


The following document sets out how the latest version of the ICPSA, Variation 4, differs from the previous version.

Changes to the ICPSA for Variation 4 [256KB]

 1 October 2022

The Letter of Offer was sent to community pharmacy contract-holders to explain and offer them ICPSA Variation 4. This letter contains key details of the offer.

Generic Letter of Offer ICPSA Variation 4 [PDF, 152 kb]

4 August 2022

 


Contract Structure

ICPSA is an evergreen contract. It includes a head agreement and three service schedules.

Head agreement
The head agreement (Parts A to E) covers background, service and quality requirements, general terms, payment and claiming terms, and definitions.

Schedule 1: Dispensing and professional advisory services

Dispensing and professional advisory services.

Schedule 2: Additional professional advisory services

Te Whatu Ora wants to recognise the clinical services pharmacists provide to patients that are not specifically linked to dispensing a medicine. This Schedule contains the Additional Professional Advisory Services payment. See the Payments section for more information.

Payments and procedures

Schedule 3: Population services

Schedule 3A – Nationally consistent services that may be offered to all or some pharmacies, and are:

  • Opioid Substitution Treatment Services (3A.1)
  • Aseptic Services (3A.2)
  • Sterile Manufacturing Services (3A.3)
  • Clozapine Services (Monitored Therapy Medicine Services) (3A.4)
  • Immunisation Services (3A.5)

Schedule 3B - these are services for which there is a national service specification, but which can be changed following the local commissioning process outlined in clause B27 and are:

  • Long-Term Conditions Pharmacy Services (3B.1)
  • Community Residential Care Pharmacy Services (3B.2)
  • Age-Related Residential Care Pharmacy Services (3B.3)
  • Special Foods Services (3B.4)
  • Community Pharmacy Anticoagulation Management Services (3B.5)
  • Smoking Cessation Services (3B.6).

Schedule 3C - any other Service Schedules that are amendments or are additional to the other services may be added here. These can be added according to the local commissioning process.


National Annual Agreement Review 

The Integrated Community Pharmacy Services Agreement provides that, before 1 October each year, there will be a national review of the nationally-consistent parts and service schedules of the Agreement, and possibly also any or all parts of Schedule 3B. The review will at least consider reasonable cost pressure adjustments, and will also consider any other matters identified as important by Te Whatu Ora, pharmacies, or the Expert Advisory Group.

It must be completed by July each year so that any changes can be adopted on 1 October.

Te Whatu Ora (or a representative on its behalf) will always participate in the review. The Ministry of Health may also participate as an observer. You may participate if you are a community pharmacy, or if you are a representative of one. The review is guided by a Terms of Reference below.

National Annual Agreement Review Terms of Reference [194kb]

July 2018

National Annual Agreement Review 2021-2022

Statement: following Review meeting - 20 July 2022

20 July 2022

Statement: following Review meeting - 30 June 2022

30 June 2022

 

Statement: following Review meeting - 8 June 2022

8 June 2022

The two presentations below were presented at the Review meeting on 8 June.

ICPSA – Primary and Community Care draft workplan – Health Priorities – interim Health New Zealand

8 June 2022

ICPSA – Expenditure Forecast and other Trends

8 June 2022                                                                                                                                                                                                                                           

National Annual Agreement Review 2020-2021

National Annual Agreement Review 2019-2020

National Annual Agreement Review 2018-2019

Letter to contract-holders November 2018 [290kb] 

November 2018 

History of the Agreement

The Community Pharmacy Services Agreement was introduced in July 2012 initially as a three year contract between individual District Health Boards (DHB) and each individual pharmacy throughout New Zealand for the provision of pharmacy services. The CPSA 12 reflected a shift to a patient-centred pharmacy delivery model which encouraged integration between health professionals.

In 2015 it was agreed that an extension was required to the Agreement and this was implemented on 1 July 2015 to run through to 30 June 2016 with an option to extend. Consequently CPSA 12 was implemented in stages and extended three times (to 30 June 2017, 30 June 2018 and 30 September 2018). 

The Integrated Community Pharmacy Services Agreement (ICPSA) came into effect on 1 October 2018, and replaced the previous contract, Community Pharmacy Services Agreement 2012 (CPSA 12).

Past versions of the contract are available here.


Please send any queries to:

Email: pharmacy@tas.health.nz


 

Back to top

Last updated: 22/12/22